Lotus Diabetes Private Limited

Lotus Diabetes Private Limited - healthcare in Delhi, India. Directors, charges & compliance details.
CIN U74900DL2012PTC233210 Incorporated 21 March 2012 ROC Delhi HQ Delhi, India
Converted to LLP Private Limited Company healthcare
Revenue · FY 2017
₹68,719
Latest filing
Net loss · FY 2017
₹5.64 Lakh
Latest filing
EBITDA · FY 2017
-₹5.1 Lakh
Latest filing
Authorised capital
₹1.5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
4
As per MCA filings
Last financials
Mar 2024
Balance sheet date

About Lotus Diabetes Private Limited

Data last updated:

Lotus Diabetes Private Limited was a private limited company based in Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the preventive healthcare segment of the healthcare sector. It was incorporated on 21 March 2012.

The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2012PTC233210.

The company had an authorised share capital of ₹1.5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Preeti Handa Singhal and Sandeep Singhal.

Its last annual general meeting (AGM) was held on 25 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at 193A Pocket A Mayur Vihar Phase – II, Delhi, India – 110091.

As per the financials filed for FY 2017, the company reported a revenue of ₹68,719. For the same year it recorded a net loss of ₹5.64 Lakh and EBITDA of -₹5.1 Lakh.

The last known website on record is lotusdiabetes.com.

Company details

CIN U74900DL2012PTC233210
Registration Number 233210
Incorporation Date 21 March 2012
ROC Delhi
Listing Status Unlisted
Company Status Converted to LLP
Compliance Status Active Compliant

Contact details

Lotus Diabetes Private Limited's registered office is in Delhi, Delhi. Its website is lotusdiabetes.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    193A Pocket A Mayur Vihar Phase – II, Delhi, India – 110091
  • Industry
    Healthcare, Preventive Health Services

To see the full contact details of Lotus Diabetes Private Limited, buy the company report.

Comprehensive company report
Lotus Diabetes Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Lotus Diabetes is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ2Medical and dental practice, Nursing, pathology, blood bank services, etc.

Financials of Lotus Diabetes Private Limited

FY 2024 filings available

Lotus Diabetes Private Limited reported revenue of ₹68,719 for FY 2017.

Revenue · FY 2017
₹68,719
Net loss · FY 2017
₹5.64 Lakh
EBITDA · FY 2017
-₹5.1 Lakh

Financial Statement Summary

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹68,719
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.1 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.64 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Lotus Diabetes Private Limited, buy the company report.

Board of directors of Lotus Diabetes Private Limited

Lotus Diabetes has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Preeti Handa SinghalDirector01 Oct 201412 Years 1 MonthsAs last reported
Sandeep SinghalDirector21 Mar 201214 Years 7 MonthsAs last reported
Ajay Kumar GuptaDirector21 Apr 20179 Years 6 MonthsAs last reported
Rupesh KapoorDirector21 Mar 201214 Years 7 MonthsAs last reported

Auditor

Lotus Diabetes Private Limited is audited by ATUL GOEL & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
ATUL GOEL & ASSOCIATESFY 2017011641N

Shareholding

The shareholding of Lotus Diabetes Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Lotus Diabetes Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Lotus Diabetes Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Lotus Diabetes Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Lotus Diabetes Private Limited has 6 board changes on record since 2012: 4 appointments and 2 cessations. The latest: Ajay Kumar Gupta ceased to be Additional Director on 26 Sep 2017.

AGM
Lotus Diabetes Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.
Filing
Lotus Diabetes Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Ajay Kumar Gupta ceased to be Additional Director.
Appointed
Ajay Kumar Gupta was appointed as Director.
Ceased
Preeti Handa Singhal ceased to be Additional Director.
Appointed
Preeti Handa Singhal was appointed as Director.
Appointed
Rupesh Kapoor was appointed as Director.
Appointed
Sandeep Singhal was appointed as Director.
Incorporation
21 Mar 2012
Lotus Diabetes Private Limited was registered on 21 Mar 2012 with Roc Delhi & aged 14 years 7 months as per MCA records.

Frequently asked questions

Lotus Diabetes has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.

Lotus Diabetes was a private limited company based in Delhi, India. The company worked in preventive health services, within the healthcare industry. It was incorporated on 21 March 2012 and is registered under CIN U74900DL2012PTC233210. For the latest details, refer to the successor LLP entity.

The CIN (Corporate Identification Number) of Lotus Diabetes is U74900DL2012PTC233210. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lotus Diabetes had 4 directors:

Lotus Diabetes was incorporated on 21 March 2012. It is registered with the Registrar of Companies, Delhi.

Lotus Diabetes can be reached through the website lotusdiabetes.com. Its registered office is in Delhi, India.

The registered office of Lotus Diabetes is at 193A Pocket A Mayur Vihar Phase – II, Delhi, India – 110091.

The latest financial statements of Lotus Diabetes on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 25 September 2024. Year-wise statements from 2015 are in the company report.

Lotus Diabetes operated in the healthcare industry, in the preventive health services segment.

Ajay Kumar Gupta ceased to be Additional Director on 26 Sep 2017. Ajay Kumar Gupta was appointed as Director on 21 Apr 2017. Preeti Handa Singhal ceased to be Additional Director on 26 Sep 2015. Lotus Diabetes has 6 board changes on record in total.